Free Trial

Hepion Pharmaceuticals (HEPA) Competitors

Hepion Pharmaceuticals logo
$0.06 0.00 (-5.00%)
As of 03:58 PM Eastern

HEPA vs. PTN, JAGX, APVO, ENTO, SCNI, SXTP, PTIX, GRTX, ONCO, and AKAN

Should you be buying Hepion Pharmaceuticals stock or one of its competitors? The main competitors of Hepion Pharmaceuticals include Palatin Technologies (PTN), Jaguar Animal Health (JAGX), Aptevo Therapeutics (APVO), Entero Therapeutics (ENTO), Scinai Immunotherapeutics (SCNI), 60 Degrees Pharmaceuticals (SXTP), Atrinsic (PTIX), Galera Therapeutics (GRTX), Onconetix (ONCO), and Akanda (AKAN). These companies are all part of the "pharmaceutical products" industry.

Hepion Pharmaceuticals vs. Its Competitors

Palatin Technologies (NYSE:PTN) and Hepion Pharmaceuticals (NASDAQ:HEPA) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

Palatin Technologies has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Hepion Pharmaceuticals has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.

In the previous week, Palatin Technologies' average media sentiment score of 0.00 equaled Hepion Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Palatin Technologies Neutral
Hepion Pharmaceuticals Neutral

Palatin Technologies has higher revenue and earnings than Hepion Pharmaceuticals. Palatin Technologies is trading at a lower price-to-earnings ratio than Hepion Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palatin Technologies$350K6.99-$40.31M-$1.55-0.06
Hepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00

Palatin Technologies' return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Palatin TechnologiesN/A N/A N/A
Hepion Pharmaceuticals N/A -812.56%-207.31%

11.5% of Palatin Technologies shares are held by institutional investors. Comparatively, 17.2% of Hepion Pharmaceuticals shares are held by institutional investors. 7.1% of Palatin Technologies shares are held by insiders. Comparatively, 0.1% of Hepion Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Palatin Technologies beats Hepion Pharmaceuticals on 6 of the 9 factors compared between the two stocks.

Get Hepion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEPA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HEPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HEPA vs. The Competition

MetricHepion PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$623K$776.90M$5.70B$9.51B
Dividend YieldN/A4.84%4.69%4.01%
P/E Ratio-0.011.4028.0720.06
Price / SalesN/A25.35449.2099.44
Price / CashN/A19.5636.2258.56
Price / Book0.046.798.665.87
Net Income-$48.93M-$4.32M$3.25B$258.55M
7 Day PerformanceN/A1.33%4.20%2.23%
1 Month PerformanceN/A3.74%10.82%12.76%
1 Year PerformanceN/A8.18%34.70%19.36%

Hepion Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HEPA
Hepion Pharmaceuticals
0.1265 of 5 stars
$0.06
-5.0%
N/A-99.8%$623KN/A-0.0120Gap Up
PTN
Palatin Technologies
N/A$0.09
-44.6%
N/AN/A$2.45M$350K-0.0630Gap Down
High Trading Volume
JAGX
Jaguar Animal Health
2.8842 of 5 stars
$2.41
+3.9%
$60.00
+2,389.6%
-93.4%$2.36M$11.69M0.0050Gap Up
High Trading Volume
APVO
Aptevo Therapeutics
2.4959 of 5 stars
$3.05
+0.7%
$219,040.00
+7,181,539.3%
-100.0%$2.29M$3.11M0.0050
ENTO
Entero Therapeutics
N/A$0.49
+4.2%
N/A-51.6%$2.25MN/A0.009
SCNI
Scinai Immunotherapeutics
1.7665 of 5 stars
$2.20
+2.3%
N/A-50.0%$2.15M$658K-0.2320
SXTP
60 Degrees Pharmaceuticals
2.8203 of 5 stars
$1.39
-3.5%
$7.00
+403.6%
+51.7%$2.12M$300K-0.033
PTIX
Atrinsic
0.5198 of 5 stars
$3.18
-7.0%
N/A-69.0%$2.01MN/A-0.242
GRTX
Galera Therapeutics
N/A$0.03
+1.2%
N/A-80.6%$1.92MN/A-0.0730
ONCO
Onconetix
0.3214 of 5 stars
$3.80
+10.5%
N/A-99.3%$1.83M$1.93M0.0012Gap Up
High Trading Volume
AKAN
Akanda
1.1474 of 5 stars
$1.24
+2.1%
N/A-60.9%$1.73M$840K0.00110

Related Companies and Tools


This page (NASDAQ:HEPA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners